Literature DB >> 9654154

Purification of a novel endothelin-converting enzyme specific for big endothelin-3.

H Hasegawa1, K Hiki, T Sawamura, T Aoyama, Y Okamoto, S Miwa, S Shimohama, J Kimura, T Masaki.   

Abstract

Endothelin-3 (ET-3), a potent vasoactive peptide, is considered to be produced from big ET-3 by endothelin-converting enzyme (ECE) like the other members of the endothelin family (ET-1 and ET-2). We purified a novel ECE from bovine iris microsomes. The purified enzyme, a 140 kDa protein by SDS-PAGE analysis, converted big ET-3 to ET-3 but not big ET-1, with a Km value of 0.14 microM for big ET-3. The conversion to ET-3 was confirmed with sandwich EIA by monoclonal antibodies, the elution profile of HPLC, and intracellular calcium mobilization in CHO-K1 cells expressing recombinant human ET(B) receptors. The conversion activity was inhibited by an inhibitor of neutral endopeptidase 24.11 (NEP) phosphoramidon. These results show that ECE-3 purified from bovine iris is a novel metalloprotease totally different from ECE-1 or ECE-2, in that the enzyme is highly specific for big ET-3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654154     DOI: 10.1016/s0014-5793(98)00554-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  The vascular endothelin system in hypertension--recent patents and discoveries.

Authors:  Meri M Hynynen; Raouf A Khalil
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2006-01

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Palmitoylation of the three isoforms of human endothelin-converting enzyme-1.

Authors:  A Schweizer; B M Löffler; J Rohrer
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.

Authors:  F Cailler; J P Zappulla; G Boileau; P Crine
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

6.  Endothelin-3-dependent pulmonary vasoconstriction in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Stéphanie Sauvageau; Eric Thorin; Louis Villeneuve; Jocelyn Dupuis
Journal:  Peptides       Date:  2008-08-15       Impact factor: 3.750

Review 7.  Eyeing endothelins: a cellular perspective.

Authors:  Ganesh Prasanna; Santosh Narayan; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 8.  Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics.

Authors:  M Barton
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 4.592

Review 9.  Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes.

Authors:  Nathalie Macours; Jeroen Poels; Korneel Hens; Carmen Francis; Roger Huybrechts
Journal:  Int Rev Cytol       Date:  2004

Review 10.  Role of endothelial dysfunction in the severity of COVID‑19 infection (Review).

Authors:  Tanya Kadiyska; Ivan Tourtourikov; Kristiyan Dabchev; Radostina Cherneva; Nikolay Stoynev; Radka Hadjiolova; Vanyo Mitev; Demetrios A Spandidos; Maria Adamaki; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2022-10-05       Impact factor: 3.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.